Re: FDA to alter rules for cancer drug cocktails
According to an article in the Journal of the National Cancer Institute, it is becoming increasingly evident that cancers are dependent on a number of altered molecular pathways and can develop diverse mechanisms of resistance to therapy with single agents. Therefore, combination regimens may provide the best hope for effective therapies with durable effects (JNCI J Natl Cancer Inst Volume103, Issue16 Pp. 1222-1226).
|